Anteris Technologies Presents Data from 100 DurAVR(R) THV Patients at PCR London Valves
Anteris Technologies Presents Data from 100 DurAVR(R) THV Patients at PCR London Valves GlobeNewswire November 17, 2025 MINNEAPOLIS and BRISBANE, Australia, Nov. 17, 2025 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) today released 30-day clinical outcomes for the DurAVR(R) THV in one hundred severe aortic stenosis patients […]